List of works - Anke Huckriede

A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro

scientific article published on 13 November 2019

A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model

scientific article published on 7 December 2017

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

scientific article published on 27 July 2017

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

scientific article

Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.

scientific article

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis

scientific article published on 12 July 2009

Cellular delivery of siRNA mediated by fusion-active virosomes.

scientific article published on January 2007

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

scientific article published on July 2007

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination

scientific article published on 22 April 2020

Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.

scientific article

Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine

scientific article

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

article

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

Cross-protective immune responses induced by sequential influenza virus infection and by sequential vaccination with inactivated influenza vaccines

article

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

scientific article

Dengue tropism for macrophages and dendritic cells: the host cell effect

scientific article

Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.

scientific article published on 21 April 2011

Development of an Orodispersible Film Containing Stabilized Influenza Vaccine

scientific article published on 08 March 2020

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations

scientific article

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study

scientific article published on 19 August 2009

Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine ⬇️

scientific article published on July 27, 2012

Effector mechanisms of influenza-specific antibodies: neutralization and beyond

scientific article published on 03 September 2018

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100 ⬇️

scientific article published on December 17, 2012

Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.

scientific article published on 21 November 2013

Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies

scientific article

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb t

scientific article

Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration

scientific article

Immunoglobulin Infusion as Therapy Against Influenza?

scientific article published on 13 April 2017

Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming

scientific article published on March 2004

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity

scientific article

Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project

scientific article

Influenza Vaccines: What Do We Want and How Can We Get It? ⬇️

scientific article published on January 1, 2011

Influenza vaccination in systemic lupus erythematosus: safe and protective?

scientific article published on 16 October 2006

Influenza virosomes in vaccine development

scientific article published on 01 January 2003

Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.

scientific article

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity

scientific article

Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo

scientific article published on May 2015

Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.

scientific article

Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.

scientific article

Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage.

scientific article

Monophosphoryl lipid A-adjuvanted virosomes with Ni-chelating lipids for attachment of conserved viral proteins as cross-protective influenza vaccine

scientific article published on 26 December 2017

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model

scientific article published on 04 August 2006

Needle-free influenza vaccination.

scientific article

Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.

scientific article

Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines ⬇️

scientific article published on January 18, 2011

Preservation of influenza virosome structure and function during freeze-drying and storage

scientific article published on January 2007

Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.

scientific article

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus

scientific article published in November 2018

Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus

scientific article published on 5 October 2014

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

scientific article

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review

scientific article

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

scientific article published in August 2009

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

scientific article

The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes ⬇️

scientific article published on October 19, 2010

The virosome concept for influenza vaccines

scientific article

Towards tailored vaccine delivery: needs, challenges and perspectives.

scientific article published on 05 January 2012

Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes.

scientific article published on 3 April 2006

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

scientific article

Virosomes for antigen and DNA delivery

scientific article

Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens

scientific article

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs.

scientific article published on March 2008

List of works by Anke Huckriede

A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro

A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis

Cellular delivery of siRNA mediated by fusion-active virosomes.

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination

Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.

Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

Cross-protective immune responses induced by sequential influenza virus infection and by sequential vaccination with inactivated influenza vaccines

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

Dengue tropism for macrophages and dendritic cells: the host cell effect

Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.

Development of an Orodispersible Film Containing Stabilized Influenza Vaccine

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study

Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine ⬇️

Effector mechanisms of influenza-specific antibodies: neutralization and beyond

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100 ⬇️

Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.

Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb t

Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration

Immunoglobulin Infusion as Therapy Against Influenza?

Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity

Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project

Influenza Vaccines: What Do We Want and How Can We Get It? ⬇️

Influenza vaccination in systemic lupus erythematosus: safe and protective?

Influenza virosomes in vaccine development

Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity

Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo

Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.

Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.

Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage.

Monophosphoryl lipid A-adjuvanted virosomes with Ni-chelating lipids for attachment of conserved viral proteins as cross-protective influenza vaccine

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model

Needle-free influenza vaccination.

Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.

Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines ⬇️

Preservation of influenza virosome structure and function during freeze-drying and storage

Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus

Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes ⬇️

The virosome concept for influenza vaccines

Towards tailored vaccine delivery: needs, challenges and perspectives.

Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes.

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

Virosomes for antigen and DNA delivery

Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs.